{"investor":{"slug":"arch-venture-partners","name":"ARCH Venture Partners","website":null,"x_handle":null,"logo":null,"type":"fund","companies":4,"deals":9,"deals_12m":1,"leads":2,"round_capital":1516000000,"latest_deal":{"date":"2026-08-06","stage":"series-b+","amount_usd":188000000,"company":{"slug":"lifemine-therapeutics","name":"LifeMine Therapeutics"}}},"profile":null,"fund_returns":[],"portfolio":[{"slug":"lifemine-therapeutics","name":"LifeMine Therapeutics","logo":"https://recentfunding.com/logo/d/lifeminetx.com.png","crypto":false,"categories":["health-bio"],"total_raised":543000000,"latest_raise":{"date":"2026-08-06","stage":"series-b+","amount_usd":75000000,"source_url":"https://www.biospace.com/business/lifemine-raises-263m-in-mission-to-improve-organ-transplant-aftercare"},"rounds_with_investor":[{"date":"2026-08-06","stage":"series-b+","amount_usd":188000000,"source_url":"https://fundraisingfox.com/companies/lifemine-therapeutics","lead":false},{"date":"2022-03-23","stage":"series-b+","amount_usd":175000000,"source_url":"https://fundraisingfox.com/companies/lifemine-therapeutics","lead":false},{"date":"2021-01-07","stage":"series-b+","amount_usd":50000000,"source_url":"https://www.biospace.com/lifemine-therapeutics-announces-50-million-series-b-financing","lead":false},{"date":"2017-09-18","stage":"series-a","amount_usd":55000000,"source_url":"https://www.biospace.com/harvard-biotech-guru-vcs-launch-lifemine-with-55-million-series-a","lead":false}]},{"slug":"seaport-therapeutics-2","name":"Seaport Therapeutics","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9wYnMudHdpbWcuY29tL3Byb2ZpbGVfaW1hZ2VzLzE3NzM0MTI4NjY2ODQ2MDAzMjAvZUdFMnF2X3FfNDAweDQwMC5wbmc","crypto":false,"categories":["health-bio"],"total_raised":325000000,"latest_raise":{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-closes-225-million-oversubscribed-series-b-financing-round/"},"rounds_with_investor":[{"date":"2024-10-21","stage":"series-b+","amount_usd":225000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-closes-225-million-oversubscribed-series-b-financing-round/","lead":false},{"date":"2024-04-09","stage":"series-a","amount_usd":100000000,"source_url":"https://seaporttx.com/press-release/seaport-therapeutics-launches-with-100-million-oversubscribed-series-a-financing-round-to-advance-novel-neuropsychiatric-medicines/","lead":true}]},{"slug":"mirador-therapeutics","name":"Mirador Therapeutics","logo":"https://recentfunding.com/logo/d/miradortx.com.png","crypto":false,"categories":["health-bio"],"total_raised":650000000,"latest_raise":{"date":"2026-01-13","stage":"series-b+","amount_usd":250000000,"source_url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4taG5ialphNGh1MGJtYmhPb0lzTk9LVTYyUHV5a3ZzTzQ2bnV4S01Bc1ltMHJULVd4elRnRFJrRnZpT29kYTdFRkJ4blVkbVRLSmhvTWpESWhRblloUTE0YmFyY2xEVDNtbDViVWtB0gFzQVVfeXFMUE45WE1iUjhDaWtTTDVCRTQ3YU05eDM5TmwzU1F0OXJjTkltaVhlNDB2MVEzb0VwNXF5dE8tVEFGOWpRMGtmSjJGaHhaeklON001YW9RRk1yZ3A5cDlRY3dHajNZX2lBamFxT3E2T09IQjY3MA?oc=5"},"rounds_with_investor":[{"date":"2024-03-21","stage":"series-a","amount_usd":400000000,"source_url":"https://www.fiercebiotech.com/biotech/investors-fund-prometheus-teams-unfinished-business-400m-new-inflammatory-biotech-mirador","lead":true}]},{"slug":"parabilis-medicines","name":"Parabilis Medicines","logo":"https://recentfunding.com/logo/d/parabilismed.com.png","crypto":false,"categories":["health-bio"],"total_raised":801000000,"latest_raise":{"date":"2026-01-08","stage":"series-b+","amount_usd":305000000,"source_url":"https://fundraisingfox.com/companies/parabilis-medicines"},"rounds_with_investor":[{"date":"2024-03-01","stage":"series-b+","amount_usd":145000000,"source_url":"https://www.biospace.com/article/fogpharma-raises-145m-in-series-e-financing-targets-solid-tumors-/","lead":false},{"date":"2022-11-21","stage":"series-b+","amount_usd":178000000,"source_url":"https://www.fiercebiotech.com/biotech/fogpharma-hauls-178m-series-d-companys-second-consecutive-triple-digit-financing-round","lead":false}]}],"top_categories":[{"key":"health-bio","label":"Health and bio","companies":4,"share":1}],"allocation":{"stages":[{"key":"series-b+","label":"Series b+","deals":6,"capital":961000000,"share":0.6666666666666666},{"key":"series-a","label":"Series a","deals":3,"capital":555000000,"share":0.3333333333333333}],"years":[{"year":"2017","deals":1,"capital":55000000,"share":0.1111111111111111},{"year":"2021","deals":1,"capital":50000000,"share":0.1111111111111111},{"year":"2022","deals":2,"capital":353000000,"share":0.2222222222222222},{"year":"2024","deals":4,"capital":870000000,"share":0.4444444444444444},{"year":"2026","deals":1,"capital":188000000,"share":0.1111111111111111}]},"co_investors":[{"slug":"milky-way-investments","name":"Milky Way Investments","logo":null,"type":"fund","shared_rounds":3,"last_shared":"2026-08-06"},{"slug":"foresite-capital","name":"Foresite Capital","logo":null,"type":"fund","shared_rounds":3,"last_shared":"2024-10-21"},{"slug":"fidelity-management-research-company","name":"Fidelity Management & Research Company","logo":null,"type":"fund","shared_rounds":3,"last_shared":"2024-03-01"},{"slug":"gv","name":"GV","logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9mcmFtZXJ1c2VyY29udGVudC5jb20vaW1hZ2VzL0swN0lTR005bnduMkI0NzlwRmxJckNlNEdrLndlYnA","type":"fund","shared_rounds":3,"last_shared":"2022-03-23"},{"slug":"blue-pool-capital","name":"Blue Pool Capital","logo":null,"type":"fund","shared_rounds":3,"last_shared":"2022-03-23"},{"slug":"mrl-ventures-fund","name":"MRL Ventures Fund","logo":null,"type":"fund","shared_rounds":3,"last_shared":"2022-03-23"},{"slug":"ra-capital-management","name":"RA Capital Management","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2026-08-06"},{"slug":"gsk","name":"GSK","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2026-08-06"},{"slug":"invus","name":"Invus","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"},{"slug":"sofinnova-investments","name":"Sofinnova Investments","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"},{"slug":"third-rock-ventures","name":"Third Rock Ventures","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"},{"slug":"puretech-health","name":"PureTech Health","logo":null,"type":"fund","shared_rounds":2,"last_shared":"2024-10-21"}]}